Announcements Trials
Browse Landscape

Phase

Phase 2 35Phase 1 12Phase 1/2 5Phase 3 3Phase NA 2Phase EARLY_PHASE1 2

Status

Completed 3Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasm Metastasis 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 16Early Intervention, Educational 16Methods 15Cyclophosphamide 15Surgical Procedures, Operative 14Standard of Care 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Cisplatin 11Filgrastim 10Educational Status 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Gemcitabine 8X-Rays 7Sorafenib 7Practice Guidelines as Topic 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Terminated × Lapatinib × Clear all
NCT01190241 2020-11-20

TSAP

Amsterdam UMC, location VUmc

Phase NA Terminated
45 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00857714 2015-07-08

Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast

Indiana University

Phase NA Terminated
1 enrolled 9 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡